logo
Plus   Neg
Share
Email

Stryker Issues Q2 Guidance - Quick Facts

Stryker (SYK) announced, for the second quarter, the company expects adjusted net earnings per diluted share to be in the range of $1.90 to $1.95. The company noted that if foreign currency exchange rates hold near current levels, second-quarter net sales will be negatively impacted by approximately 1.5% and net earnings per share will be negatively impacted by $0.01 to $0.03. Analysts polled by Thomson Reuters expect the company to report profit per share of $1.96, for the quarter. Analysts' estimates typically exclude special items.

The company now expects 2019 organic net sales growth to be in the range of 6.8% to 7.5% and projects adjusted net earnings per diluted share to be in the range of $8.05 to $8.20. If foreign currency exchange rates hold near current levels, the company expects full year net sales will be negatively impacted by approximately 1.0%, and earnings per share to be negatively impacted by $0.05 to $0.10. Analysts polled by Thomson Reuters expect the company to report profit per share of $8.13, for the fiscal year.

For the first-quarter, adjusted net earnings per diluted share was $1.88, up 11.9% from prior year. On average, 29 analysts polled by Thomson Reuters expected the company to report profit per share of $1.84 for the quarter.

For the first-quarter, consolidated net sales were $3.5 billion, an increase of 8.5% from prior year, or up 10.6% in constant currency. Organic net sales rose 7.3% in the quarter. Analysts expected revenue of $3.52 billion for the quarter.

Shares of Stryker were down more than 3% after hours.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT